These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11255560)

  • 1. Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: therapeutic implications.
    Millar RP; Zhu YF; Chen C; Struthers RS
    Br Med Bull; 2000; 56(3):761-72. PubMed ID: 11255560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-peptidic GnRH receptor antagonists.
    Armer RE; Smelt KH
    Curr Med Chem; 2004 Nov; 11(22):3017-28. PubMed ID: 15544487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Development of Non-Peptide GnRH Antagonists.
    Tukun FL; Olberg DE; Riss PJ; Haraldsen I; Kaass A; Klaveness J
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29232843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
    Harrison GS; Wierman ME; Nett TM; Glode LM
    Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of GnRH antagonists in the treatment of precocious puberty.
    Roth C
    Expert Opin Investig Drugs; 2002 Sep; 11(9):1253-9. PubMed ID: 12225246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GnRH agonists and antagonists in cancer therapy.
    Chengalvala MV; Pelletier JC; Kopf GS
    Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):399-410. PubMed ID: 14529448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis.
    Kim SM; Yoo T; Lee SY; Kim EJ; Lee SM; Lee MH; Han MY; Jung SH; Choi JH; Ryu KH; Kim HT
    Life Sci; 2015 Oct; 139():166-74. PubMed ID: 26321528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands.
    Heitman LH; Ijzerman AP
    Med Res Rev; 2008 Nov; 28(6):975-1011. PubMed ID: 18561294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ovulation: comparison between the mechanism of action of steroids and GnRH analogues.
    Bouchard P; Wolf JP; Hajri S
    Hum Reprod; 1988 May; 3(4):503-6. PubMed ID: 3292571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
    Yen SS
    Fertil Steril; 1983 Mar; 39(3):257-66. PubMed ID: 6130985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
    Apter D; Bützow TL; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?
    Montagnani Marelli M; Moretti RM; Januszkiewicz-Caulier J; Motta M; Limonta P
    Curr Cancer Drug Targets; 2006 May; 6(3):257-69. PubMed ID: 16712461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone and its clinical applications.
    Loucopoulos A; Ferin M
    Obstet Gynecol Annu; 1984; 13():275-88. PubMed ID: 6326010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone and its analogs.
    Conn PM; Crowley WF
    Annu Rev Med; 1994; 45():391-405. PubMed ID: 8198390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mammalian receptor for the evolutionarily conserved type II GnRH.
    Millar R; Lowe S; Conklin D; Pawson A; Maudsley S; Troskie B; Ott T; Millar M; Lincoln G; Sellar R; Faurholm B; Scobie G; Kuestner R; Terasawa E; Katz A
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9636-41. PubMed ID: 11493674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical consequences of the administration of a GnRH antagonist during the menstrual cycle].
    Gordon K
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S7-10. PubMed ID: 15643677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of pituitary gonadotropin-releasing hormone receptors by pulsatile gonadotropin-releasing hormone injections in male rats. Modulation by testosterone.
    Garcia A; Schiff M; Marshall JC
    J Clin Invest; 1984 Sep; 74(3):920-8. PubMed ID: 6088587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GnRH analogues for contraception.
    Fraser HM
    Br Med Bull; 1993 Jan; 49(1):62-72. PubMed ID: 8324616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
    Roth C; Leonhardt S; Seidel C; Luft H; Wuttke W; Jarry H
    Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.